Claus Møldrup. Professor, PhD (pharm).
Mail: cm(at)farma.ku.dk
Press phone: +45 22887627
Claus Møldrup became professor in 2010 in continuation of a period as assistant and associate professor since 2000. He graduated with a MSc degree in pharmacy in 1996, and earned his PhD in 2000. His dissertation was on the risk of future drugs from the perspective of both experts and lay people.
His prolific research results are published in national as well as international scientific journals, and he is also the author of two books and several chapters in anthologies .
The future is a recurring theme in Claus Møldrup's work, although he wants his results to be immediately applicable for patients, authorities and drug producers. His research focus covers a wide spectrum from healthy people's use of drugs, lifestyle medicine, doping, to the ethical and legal aspects of pharmacogenetics.
Risk theory is Claus Møldrup's primary theoretical interest, particularly with regard to risk society. His strengths in methodology lie in his understanding of how to utilize IT potential in collecting data. He is a serious Internet user and sees cell phones as tools for data collection in future.
Claus Møldrup makes a special point of conveying his knowledge in a way that can be understood by the general public. His popular appeal has resulted in innumerable interviews for newspapers, radio and television and more than 300 lectures.
Recent and comming publications (2004-2008)
Oestergaard, S., Møldrup, C. Application of pharmacogenomics to clinical problems in depression. The pharmacogenomics journal. 2008 pending review
Møldrup, C.Beyond pharmacogenetics - individualized medicine in a holistic perspective. 2008; pending review
Møldrup, C. Søndergaard, B. Stein. J. Mobile phone Short Messaging Service (SMS) for optimizing asthma treatment has no healthcare related effects ? a controlled trial." eTELEMED 2009, International Conference on eHealth, Telemedicine, and Social Medicine. Accpted 2009
Jacobsen, R. Møldrup, C. Christrup, L, Sjøgren, P. The Danish version of the Medication Adherence ReportScale: Preliminary Validation in Cancer Pain Patients. Pain Practice, Volume ••, Issue ••, 2008
Jacobsen, R. Møldrup, C. Christrup, L, Sjøgren, P. Patient-related barriers to cancer pain management: a systematic exploratory literature review. Scandinavian Journal of Caring Sciences, Volume ••, Issue ••, 2008
Rehne J, Møldrup, C. Danes’ awareness of and attitude towards direct-to-consumer advertising (DTC-A) of prescription drugs. A quantitative survey of 3000 respondents. Journal Medical Marketing 8,1,31-38.2008
Nielsen L, Møldrup C. Lay perspective on pharmacogenetics and application of this in future drug treatment. – a Danish quantitative survey. New Genetics and Society 26,3,309-325, 2007.
Jacobsen, R. Sjøgren, P, Møldrup, C. Christrup, L., Physician-related barriers to cancer pain management: systematic review. Journal of Opioid Management 3,4,207-214, 2007
Møldrup, C. “Buisness as unusual” Editorial Journal Medical Marketing; 7,4,275 2007
Nielsen L, Møldrup C. The Diffusion of Innovation: Factors influencing the uptake of pharmacogenetic from a lay perspective. Community Genetics; 10, 4, 231-241, 2007;
Nielsen L, Møldrup C. The Diffusion of Innovation: Factors influencing the uptake of pharmacogenetic from a lay perspective. Community Genetics 2007; In print
Møldrup, C. Kruse, PR. Drugs – product or service. Journal of Medical Marketing. 6,4, 282-286 2006.
Nielsen L, Møldrup C. Lay perspective on pharmacogenomics – a literature review. Personalized medicine. 3,3, 311-316, 2006.
Møldrup, C. Hansen, RR. Danes’ acceptance of drug use for non-disease conditions. Current Medical Research Opinion. 22; 4; 777-780. 2006
Møldrup C. No cure, No pay - consumer / patient perspective. Journal of medical marketing 6;1: 31-37 2006
Møldrup. C. The prospects and bioethical dimensions of expanding the meaning of pharmacogenomics to compass individualized pharmacotherapy. Personalized medicine 2005 (2), 168-169.
Møldrup C, No cure, no pay. BMJ 330:1262-1264, 2005.
Møldrup C. Lifestyle medicines: proposing a widely acceptable definition - original review. Pending review. 2005
Møldrup C, Knudsen P, and Traulsen JM. Betegnelsen lykkepiller er et dansk og problematisk fænomen. Ugeskrift for Læger (21):2282-2285, 2005.
Møldrup C, Livsstilsmedicin og farmakogenetik -individualiseret lægemiddelterapi. Ugeskrift for Læger (20):2150-2153, 2005.
Møldrup C. Bioethical implications of clinical pharmacogenetics. Clinical Neuropsychiatry Journal of Treatments Evaluation 2. 2004.
Møldrup, C. Introduction to lifestyle medicine. In Ten Tens: 10 pharmacotherapy developments. EJHP 2004:6, 54
Anhøj J, Møldrup C. Feasibility of Collecting Diary Data From Asthma Patients Through Mobile Phones and SMS (Short Message Service): Response Rate Analysis and Focus Group Evaluation From a Pilot Study. Journal of Medical Internet Research 2004; 6(4):e42.
Møldrup C. The use of the terms "lifestyle medicines" or "lifestyle drugs". Pharmacy World & Science 2004; 26:193-196.
Møldrup, C. Pengene tilbage-konceptet er en ny dimension i rationel farmakoterapi. Ugeskrift for Læger. 2004, nr. 26, 31
------
Press pictures
|
(cm_20800_01.jpg) [ Download ] |
248 K |
|
(cm_18sh800_01.jpg) [ Download ] |
253 K |
|
(cm_30sh800_01.jpg) [ Download ] |
207 K |
Pictures by Jacob Crawfurd
CV
|
266 K | |
|
|
152 K |
Ethical codex
|
|
83 K |
Scientific editing
For authors in need of English proofreading, I recommend American Journal Experts (AJE) for their medical and scientific editing service. I have used AJE multiple times and am very happy with their careful editors, good prices and quick turnaround times. After using AJE, my research articles were accepted and published in international journals
